Bayer wins Yaz case

Bayer Australia says it is “delighted” by a successful outcome in its court case on the patent of the oral contraceptives Yaz and Yasmin.

The Full Federal Court of Australia has dismissed appeals by Generic Health/Lupin Australia and Apotex, upholding the trial judge's earlier decision that Generic Health Pty Ltd and Lupin Australia Pty Ltd infringed claims 3 and 11 of Bayer’s Australian Patent entitled "pharmaceutical combination of ethinyloestradiol and drospirenone for use as an oral contraceptive" by marketing and selling the 3 mg drospirenone and 30 mcg ethinyloestradiol oral